Noxopharm Ltd (NOX) - Total Liabilities

Latest as of December 2025: AU$5.88 Million AUD ≈ $4.16 Million USD

Based on the latest financial reports, Noxopharm Ltd (NOX) has total liabilities worth AU$5.88 Million AUD (≈ $4.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Noxopharm Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Noxopharm Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Noxopharm Ltd's total liabilities have evolved over time, based on quarterly financial data. See NOX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Noxopharm Ltd Competitors by Total Liabilities

The table below lists competitors of Noxopharm Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Yorbeau Resources Inc TO:YRB	Canada	CA$276.88K
EMMERSON PLC O.N. F:4UM	Germany	€826.00K
Smartiks Yazilim AS IS:SMART	Turkey	TL107.22 Million
Algorae Pharmaceuticals Ltd AU:1AI	Australia	AU$111.25K
Korea Information Engineering Services Co. Ltd KQ:039740	Korea	₩69.38 Billion
Picogram Co. Ltd. KQ:376180	Korea	₩19.63 Billion
Atalaya Mining Ltd LSE:ATYM	UK	GBX165.47 Million
Passat Société Anonyme PA:PSAT	France	€26.47 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Noxopharm Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Noxopharm Ltd (NOX) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.02	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-5.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Noxopharm Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Noxopharm Ltd (2016–2025)

The table below shows the annual total liabilities of Noxopharm Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$3.89 Million ≈ $2.75 Million	+201.99%
2024-06-30	AU$1.29 Million ≈ $911.78K	+22.12%
2023-06-30	AU$1.06 Million ≈ $746.61K	-57.38%
2022-06-30	AU$2.48 Million ≈ $1.75 Million	-65.02%
2021-06-30	AU$7.08 Million ≈ $5.01 Million	-1.63%
2020-06-30	AU$7.19 Million ≈ $5.09 Million	+25.10%
2019-06-30	AU$5.75 Million ≈ $4.07 Million	+30.66%
2018-06-30	AU$4.40 Million ≈ $3.11 Million	+1119.07%
2017-06-30	AU$361.04K ≈ $255.46K	+37.95%
2016-06-30	AU$261.72K ≈ $185.18K	--

About Noxopharm Ltd

AU:NOX Australia Biotechnology

Market Cap

$17.17 Million

AU$24.27 Million AUD

Market Cap Rank

#25579 Global

#1106 in Australia

Share Price

AU$0.08

Change (1 day)

+0.00%

52-Week Range

AU$0.06 - AU$0.13

All Time High

AU$1.58